HLA class II neoantigen presentation for CD4 <sup>+</sup> T cell surveillance in HLA class II-negative colorectal cancer
Satoru Matsumoto(Toyonaka Municipal Hospital), Toshihiko Torigoe(Sapporo Medical University)
Cited by 5
Related Papers
Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
|JCI Insight|2021|33
Crisscross CTL Induction by SYT-SSX Junction Peptide and Its HLA-A*2402 Anchor Substitute
|The Journal of Immunology|2004|32